Clinical Trial Update: Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a four-drug regimen (nab-paclitaxel, gemcitabine, cisplatin, and hydroxychloroquine) in untreated pancreatic adenocarcinoma, includin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)
• Plaquenil (hydroxychloroquine)
• Platinol (cisplatin)

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING